FR2711989B1 - Nouvelles isoquinoléines, leur préparation et leur utilisation comme médicaments. - Google Patents

Nouvelles isoquinoléines, leur préparation et leur utilisation comme médicaments.

Info

Publication number
FR2711989B1
FR2711989B1 FR9413108A FR9413108A FR2711989B1 FR 2711989 B1 FR2711989 B1 FR 2711989B1 FR 9413108 A FR9413108 A FR 9413108A FR 9413108 A FR9413108 A FR 9413108A FR 2711989 B1 FR2711989 B1 FR 2711989B1
Authority
FR
France
Prior art keywords
isoquinolines
drugs
preparation
new
new isoquinolines
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR9413108A
Other languages
English (en)
Other versions
FR2711989A1 (fr
Inventor
Reto Naef
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz AG filed Critical Sandoz AG
Publication of FR2711989A1 publication Critical patent/FR2711989A1/fr
Application granted granted Critical
Publication of FR2711989B1 publication Critical patent/FR2711989B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
    • C07D217/06—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with the ring nitrogen atom acylated by carboxylic or carbonic acids, or with sulfur or nitrogen analogues thereof, e.g. carbamates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C07D217/26—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/12—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
    • C07D217/14—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring other than aralkyl radicals
    • C07D217/16—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring other than aralkyl radicals substituted by oxygen atoms
FR9413108A 1993-11-05 1994-10-28 Nouvelles isoquinoléines, leur préparation et leur utilisation comme médicaments. Expired - Fee Related FR2711989B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB939322828A GB9322828D0 (en) 1993-11-05 1993-11-05 Organic compounds

Publications (2)

Publication Number Publication Date
FR2711989A1 FR2711989A1 (fr) 1995-05-12
FR2711989B1 true FR2711989B1 (fr) 1996-06-14

Family

ID=10744697

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9413108A Expired - Fee Related FR2711989B1 (fr) 1993-11-05 1994-10-28 Nouvelles isoquinoléines, leur préparation et leur utilisation comme médicaments.

Country Status (26)

Country Link
US (1) US5747506A (fr)
EP (1) EP0664289A3 (fr)
JP (1) JPH07188176A (fr)
KR (1) KR950014073A (fr)
CN (1) CN1051998C (fr)
AT (1) AT404940B (fr)
AU (1) AU685852B2 (fr)
CA (1) CA2135000A1 (fr)
CH (1) CH688478A5 (fr)
CZ (1) CZ282329B6 (fr)
DE (1) DE4438737A1 (fr)
FI (1) FI945191A (fr)
FR (1) FR2711989B1 (fr)
GB (2) GB9322828D0 (fr)
HK (1) HK1005776A1 (fr)
HU (1) HU217120B (fr)
IL (1) IL111518A (fr)
IT (1) IT1273993B (fr)
NO (1) NO302293B1 (fr)
NZ (1) NZ264851A (fr)
PE (1) PE30395A1 (fr)
PL (1) PL178210B1 (fr)
RU (1) RU2144027C1 (fr)
SK (1) SK280298B6 (fr)
TW (1) TW353067B (fr)
ZA (1) ZA948738B (fr)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9312853D0 (en) 1993-06-22 1993-08-04 Euro Celtique Sa Chemical compounds
US5591776A (en) 1994-06-24 1997-01-07 Euro-Celtique, S.A. Pheynl or benzyl-substituted rolipram-based compounds for and method of inhibiting phosphodiesterase IV
US5922751A (en) 1994-06-24 1999-07-13 Euro-Celtique, S.A. Aryl pyrazole compound for inhibiting phosphodiesterase IV and methods of using same
US6166041A (en) 1995-10-11 2000-12-26 Euro-Celtique, S.A. 2-heteroaryl and 2-heterocyclic benzoxazoles as PDE IV inhibitors for the treatment of asthma
US6075016A (en) 1996-04-10 2000-06-13 Euro-Celtique S.A. 6,5-fused aromatic ring systems having enhanced phosphodiesterase IV inhibitory activity
ID19155A (id) * 1996-12-13 1998-06-18 Tanabe Seiyaku Co Turunan-turunan piridin, pembuatannya dan intermediet untuk pembuatannya
US5919794A (en) * 1998-05-11 1999-07-06 Virginia Commonwealth University Methods of using pharmaceutical tetrahydroisoquinolines
US6200771B1 (en) * 1998-10-15 2001-03-13 Cell Pathways, Inc. Method of using a novel phosphodiesterase in pharmaceutical screeing to identify compounds for treatment of neoplasia
IL132407A0 (en) * 1998-10-21 2001-03-19 Pfizer Prod Inc Method for treating congestive heart failure
DE19930614A1 (de) * 1999-07-02 2001-01-04 Mann & Hummel Filter Filtereinsatz
JP5038568B2 (ja) 1999-08-21 2012-10-03 ニコメッド ゲゼルシャフト ミット ベシュレンクテル ハフツング 協力剤の組合せ物
CA2402413A1 (fr) * 2000-03-14 2001-09-20 The University Of Western Ontario Compositions et procedes exercant un effet sur l'osteogenese
AU2002224835A1 (en) * 2000-11-14 2002-05-27 Byk Gulden Lomberg Chemische Fabrik G.M.B.H. Dihydroisoquinolines as novel phosphodiesterase inhibitors
AU2002229541B2 (en) 2000-11-14 2007-01-18 Altana Pharma Ag (dihydro)isoquinoline derivatives as phosphodiesterase inhibitors
DE10229762A1 (de) * 2002-07-03 2004-01-22 Aventis Pharma Deutschland Gmbh Pyrazoloisoquinolinenderivaten zur Inhibierung von NFkappaB-induzierende Kinase
US7772188B2 (en) 2003-01-28 2010-08-10 Ironwood Pharmaceuticals, Inc. Methods and compositions for the treatment of gastrointestinal disorders
BRPI0409229A (pt) 2003-04-01 2006-03-28 Applied Research Systems inibidores das fosfodiesterases na infertilidade
US7795385B2 (en) * 2004-12-17 2010-09-14 Bexar Global, Inc. Use of bombesin/gastrin-releasing peptide antagonists for the treatment of inflammatory conditions, acute lung injury and bipolar disorder
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
US7879802B2 (en) 2007-06-04 2011-02-01 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
EP3239170B1 (fr) 2008-06-04 2019-03-20 Synergy Pharmaceuticals Inc. Agonistes de guanylate cyclase utile dans le traitement de troubles gastro-intestinaux, d'une inflammation, d'un cancer et d'autres troubles
EP3241839B1 (fr) 2008-07-16 2019-09-04 Bausch Health Ireland Limited Agonistes de guanylate cyclase utiles pour le traitement de troubles gastro-intestinaux, inflammatoires, cancéreux et autres
US8299055B2 (en) * 2008-10-02 2012-10-30 Asahi Kasei Pharma Corporation 8-substituted isoquinoline derivative and the use thereof
BRPI0920246A2 (pt) 2008-10-17 2017-06-27 Winconsin Alumni Res Foundation método de preparação de alfa-beta peptídios biologicamente ativos.
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
CN108676076A (zh) 2011-03-01 2018-10-19 辛纳吉制药公司 制备鸟苷酸环化酶c激动剂的方法
US9545446B2 (en) 2013-02-25 2017-01-17 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase and their uses
CA2905435A1 (fr) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Compositions utiles pour le traitement de troubles gastro-intestinaux
US9708367B2 (en) 2013-03-15 2017-07-18 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase and their uses
JP6606491B2 (ja) 2013-06-05 2019-11-13 シナジー ファーマシューティカルズ インコーポレイテッド グアニル酸シクラーゼｃの超高純度アゴニスト、その作成および使用方法
IL280864B2 (en) 2013-08-09 2024-03-01 Ardelyx Inc Compounds and methods for inhibiting phosphate transport
WO2020237096A1 (fr) 2019-05-21 2020-11-26 Ardelyx, Inc. Combinaison pour baisser le phosphate sérique chez un patient

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB645139A (en) * 1946-10-22 1950-10-25 Servita Gyogyszeryar Es Vegyip Improved process for the production of isoquinoline derivatives
GB1400425A (en) * 1971-09-22 1975-07-16 Rolland Sa A Substituted 3-hydroxymethyl-isoquinolines and derivatives
US3878215A (en) * 1971-12-01 1975-04-15 Sandoz Ag 2-Alkyl-3-substituted-4-aryl isoquinolines
US4018927A (en) * 1973-12-17 1977-04-19 The Regents Of The University Of Michigan Treatment of proliferating skin diseases with papaverine alkaloids
KR840002104B1 (ko) * 1980-08-08 1984-11-15 부자 앙드레 신규 이소퀴놀린 유도체의 제법
HU183479B (en) * 1981-06-16 1984-05-28 Chinoin Gyogyszer Es Vegyeszet Process for producing new 6,7-diethoxy-1-aracket-4-ethoxy-3-hydroxy-benzyl-bracket closed-3,4-dihydroisoquinolin
DE3244594A1 (de) * 1982-12-02 1984-06-07 Hoechst Ag, 6230 Frankfurt 1-phenylisochinolinderivate und verfahren zu ihrer herstellung, diese verbindung enthaltende pharmazeutische praeparate und deren anwendung
GB8328052D0 (en) * 1983-10-20 1983-11-23 Beecham Group Plc Compounds
US4761403A (en) * 1986-04-09 1988-08-02 Abbott Laboratories Lipoxygenase inhibiting compounds
CA1330560C (fr) * 1986-05-21 1994-07-05 Maurits E. A. Vandewalle Derives di- et tetrahydroisoquinoline
HU196758B (en) * 1986-05-21 1989-01-30 Gyogyszerkutato Intezet Process for production of 3-hidroxi-methil-quinolines and medical compositions containing them
GB8800397D0 (en) * 1988-01-08 1988-02-10 Sandoz Ltd Improvements in/relating to organic compounds
GB9027055D0 (en) * 1990-12-13 1991-02-06 Sandoz Ltd Organic compounds

Also Published As

Publication number Publication date
ITRM940706A1 (it) 1996-05-03
JPH07188176A (ja) 1995-07-25
US5747506A (en) 1998-05-05
AT404940B (de) 1999-03-25
PL305705A1 (en) 1995-05-15
GB9421985D0 (en) 1994-12-21
PE30395A1 (es) 1995-10-25
HU9403184D0 (en) 1994-12-28
IL111518A (en) 1999-06-20
NO302293B1 (no) 1998-02-16
CN1106801A (zh) 1995-08-16
CZ269894A3 (en) 1995-07-12
GB2283488A (en) 1995-05-10
EP0664289A2 (fr) 1995-07-26
HK1005776A1 (en) 1999-01-22
IL111518A0 (en) 1995-01-24
EP0664289A3 (fr) 1995-09-13
ATA204894A (de) 1998-08-15
NZ264851A (en) 1996-04-26
TW353067B (en) 1999-02-21
CN1051998C (zh) 2000-05-03
ITRM940706A0 (it) 1994-11-03
HU217120B (hu) 1999-11-29
FR2711989A1 (fr) 1995-05-12
ZA948738B (en) 1996-05-06
AU685852B2 (en) 1998-01-29
GB9322828D0 (en) 1993-12-22
NO944187D0 (no) 1994-11-03
RU2144027C1 (ru) 2000-01-10
DE4438737A1 (de) 1995-05-11
FI945191A0 (fi) 1994-11-03
HUT71350A (en) 1995-11-28
CZ282329B6 (cs) 1997-06-11
AU7761094A (en) 1995-05-18
NO944187L (no) 1995-05-08
SK131994A3 (en) 1995-06-07
CH688478A5 (de) 1997-10-15
RU94040170A (ru) 1996-10-10
CA2135000A1 (fr) 1995-05-06
GB2283488B (en) 1997-12-03
KR950014073A (ko) 1995-06-15
PL178210B1 (pl) 2000-03-31
SK280298B6 (sk) 1999-11-08
IT1273993B (it) 1997-07-14
FI945191A (fi) 1995-05-06

Similar Documents

Publication Publication Date Title
FR2711989B1 (fr) Nouvelles isoquinoléines, leur préparation et leur utilisation comme médicaments.
FR2681326B1 (fr) Nouveaux derives peptidiques, leur preparation et leur utilisation comme medicaments.
FR08C0025I2 (fr) Heterocycles bicycliques disubstitues, production et utilisation comme medicaments
FR2575750B1 (fr) Derives de la piperidine et de la pyrrolidine, leur preparation et leur utilisation comme medicaments
NL187785C (nl) Chirurgische kraminrichting.
FI864272A0 (fi) Infusionsloesningar av 1-cyklopropyl-6-fluor-1,4-dihydro-4-oxo-7-(1-piperazinyl)-kinolin-3 -karboxylsyra.
ITGE930012A0 (it) Cannula laparoscopica.
FR2744449B1 (fr) Nouvelles piperazines aromatiques derivees de cycloazanes substitues, ainsi que leur procede de preparation, les compositions pharmaceutiques et leur utilisation comme medicaments
FR2660556B1 (fr) Microspheres, leur procede de preparation et leur utilisation.
FR2710915B1 (fr) Dérivés de pipéridine, leur préparation et leur utilisation en thérapeutique.
OA09432A (fr) N-aryl-azétidinones, leur procédé de préparation et leur utilisation comme inhibiteurs des élastases.
FR2692147B1 (fr) Microsphères en polymère biorésorbable exemptes de tensioactif, leur préparation et leur application comme médicament.
FR2511003B1 (fr) Alacaloides ergopeptidiques, leur preparation et leur utilisation comme medicaments
FR2706469B1 (fr) Polyisobutènes polyfonctionnels, leur préparation, leur formulation et leur utilisation.
FR2560196B1 (fr) Nouvelles 8a-acylaminoergolines, leur preparation et leur utilisation comme medicaments
DE3689919T2 (de) Polyfluorisoxazolamine, ihre Herstellung und Anwendung.
BE883080A (fr) Nouvelles pyrazinobenzodiazepines, leur preparation et leur application comme medicaments
FR2536072B1 (fr) Nouveaux derives de la quinazoline, leur preparation et leur utilisation comme medicaments
NO901257L (no) Kinolinderivater.
FR2612185B1 (fr) Derives oxo-isoindolinyliques optiquement actifs, leur preparation et leur utilisation comme medicaments
MA21032A1 (fr) Derives d'imidazole , leur preparation et leur utilisation comme fongicides .
FR2666812B1 (fr) Enzymes immobilisees, leur preparation et leur utilisation.
FR2607810B1 (fr) Nouveaux derives azoliques, leur preparation et leur utilisation comme medicaments
FR2609715B1 (fr) Nouveaux diazepinoindoles, leur preparation et leur utilisation comme medicaments
FI862897A (fi) Nytt antitrombosmedel baserat pao glykosaminoglykaner, dess framstaellningsfoerfarande och farmaceutiska kompositioner.

Legal Events

Date Code Title Description
TP Transmission of property
ST Notification of lapse